Skip to content
healthcare.dev

ESLICARBAZEPINE ACETATE

NDC 59651-533, ESLICARBAZEPINE ACETATE, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-533
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216481
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-533 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ESLICARBAZEPINE ACETATE200 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
59651-533-305965105333030 TABLET in 1 BOTTLE (59651-533-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2067fb77-9657-44da-b430-02e8a4efacb5
  • NADAC price for package 59651053330

    GET /v1/drugs/nadac/59651053330

Use it

Look up 59651-533 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-533 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-533. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.